Showing posts with label #Mylan. Show all posts
Showing posts with label #Mylan. Show all posts

Tuesday, 14 March 2017

Mar 14, 2017 - Market Update

Short recap

Europe opened lower
Brexit bill approved without any amendments – victory for May
Not to be invoked before Mar 27
FTSE pushed to retest the highs
14 mln Americans to lose medicare coverage is a bit bitter pill for Trump and his administration to swallow
Merkel to meet Trump on Friday instead of today due to flight cancellation (NY area bad weather conditions)


Intel buying Mobileye (USD 15.3 bln) to enter the field of autonome driving with direct competition of Nvidia and Qualcomm
Building a one place to do get all, so car makers can get all what they need in driverless technology and equipment
Mylan settled with Roche to produce a biosimilar version of breast cancer drug
Vista Equity Partners buying DH Corp (CAD 4.8 bln) to bet on fintech future
Morgan Stanley taking wealth management more digital and hiring tech specialist to train advisors
Blackstone to set up EU headquarters in Luxembourg
US cyclicals reversed yesterday and VIX dropped, proving we are in a bullish trend going to FOMC

EUR – a nice correction of Friday move in many crosses
But let’s wait for FOMC and market reaction
Thursday to be a “D” day (decision day) for EURUSD and its direction

USD – getting muscles ahead of FOMC

FX options

Vols keep falling with Implied still above Realized
Despite risk events like Dutch elections and FOMC
Once these events are off the table, expecting further drop in vols
Looking further to French election vols on election days decline in line with overall market
Seeing the vols cheap considering that Le Pen is still strong part of the presidential race
May be vols pricing is derived from current market sentiments? It doesn’t really make sense.

GBP vols no reaction to Brexit bill approval
Just spot dropped to 1.2123 from around 1.2200
Vols in line with the market heading lower

Trys and Bund yields higher (2.62% and 0.48% respectively)
Peripheral spreads unchanged, waiting for Dutch elections tomorrow
GE-FR spread steady at 61 bps, to watch reaction to Dutch elections results

Oil still second guessing on how big and sustainable the supply overhang is
WTI and Brent oversold, resistance 50.60 and 53.30 respectively
US shale production rising

Gold range bound
Levels: 1177, 1193 and 1210, 1221

Data

GE: ZEW Economic Survey – expecting higher
EZ: Industrial Production – expecting higher
US: NFIB Small Business Optimism Index – to keep positive

This week is busy:

Mar 13-14 – US budget draft to show first details of Trumps stimulus plan
Mar 15 – FOMC (25 bps hike expected)
Mar 15 – Dutch elections (polling stations close at 2000 GMT, first exit polls to start right after)
Mar 15 – US debt ceiling deadline
Mar 16 – BoJ meeting (right after Fed hiking…)
Mar 16 – SNB meeting (to be watched as EURCHF is not behaving in a normal way)
Mar 16 – BoE meeting
Mar 17 – Merkel meeting Trump
Mar 17-18 – G20 FinMin meeting

Should you have any questions feel free to contact me anytime.

Good luck Champs!

Mr Hawk



DISCLAIMER: This material was created for informational purposes only and represents the Land of Trading team’s view of the past and current economic and capital market environment. It is not an investment advice and should not be viewed that way at all, and the creators of this material cannot be held liable for any potential losses resulting from trading, where despite this disclaimer someone would consider this material as an investment advice. All rights reserved ©2016. Contact: landoftradingATgmailDOTcom

Sunday, 26 February 2017

Feb 26, 2017 - Q4 Earnings - Week 7

Q4 Earnings – Week 2017-02-26

As we are moving closer to the end of earnings season we have got more international and medium to small companies reporting. Last week Royal Bank of Canada hit the CAD 3 bln earnings mark, actually for the first time. The investors were pleased by 24% rise in earnings, 5% hike in dividends. The good news was that all areas performed well.


Target – may not be the top performer this week as holiday season was hit by discounts and competition

Mylan – market is interested to see how the company is effected by ongoing price investigation and facing competition in generics

Salesforce.com – expecting better results on the back of overwhelming demand for sales and marketing software

Valeant Pharmaceuticals – nothing new here, the company is still struggling under enormous debt burden, likely the sales of non-core assets may not be sufficient

VTB Bank and Sberbank – the Trump stance on Russia is changing, Western sanctions being in place, domestic economic still not out of the woods but having better prospects for higher oil price, all of that has definitely a direct impact on financial sector in Russia. Let’s see how the banks do in this environment.

Name
Exchange
Date
Estimated EPS
Estimated Revenue
CST Brands
US
Mon
0.36
2,460
Perrigo
US
Mon
1.62
1,340
Priceline.com
US
Mon
13.01
2,330
VimpelCom
RU
Mon
0.04
2,210
BMO
CA
Tue
1.88
Bank of Nova Scotia
CA
Tue
1.57
Target
US
Tue
1.50
Valeant Pharmaceuticals
CA
Tue
1.83
2,330
MAN
GE
Wed
BestBuy
US
Wed
1.67
ENI
IT
Wed
Evraz
RU
Wed
3,700
Lowe's
US
Wed
0.79
Luxottica
IT
Wed
Mylan
US
Wed
1.42
3,220
National Bank of Canada
CA
Wed
1.26
Office Depot
US
Wed
0.10
2,730
VTB Bank
RU
Wed
Anheuser Busch Inbev
BE
Thu
0.83
13,690
Canadian Natural Resources
CA
Thu
0.10
3,140
Costco
US
Thu
1.36
Deutsche Telekom
GE
Thu
Embraer
BR
Thu
0.73
1,870
LafargeHolcim
CH
Thu
Sberbank
RU
Thu
TD Bank
CA
Thu
1.27
Parmalat
IT
Fri

Good luck Champs!

Mr Hawk



DISCLAIMER: This material was created for informational purposes only and represents the Land of Trading team’s view of the past and current economic and capital market environment. It is not an investment advice and should not be viewed that way at all, and the creators of this material cannot be held liable for any potential losses resulting from trading, where despite this disclaimer someone would consider this material as an investment advice. All rights reserved ©2016. Contact: landoftradingATgmail.com